STOCK TITAN

IRIDEX Corp (IRIX) CFO adds 5,004 common shares in open-market buy

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

IRIDEX Corp Chief Financial Officer Romeo R. Dizon reported an open-market purchase of 5,004 shares of common stock at $1.00 per share. Following this transaction, he directly holds 126,004 shares of IRIDEX common stock, modestly increasing his personal stake in the company.

Positive

  • None.

Negative

  • None.
Insider Dizon Romeo R
Role Chief Financial Officer
Bought 5,004 shs ($5K)
Type Security Shares Price Value
Purchase Common Stock 5,004 $1.00 $5K
Holdings After Transaction: Common Stock — 126,004 shares (Direct, null)
Footnotes (1)
Shares purchased 5,004 shares Open-market purchase of common stock
Purchase price $1.00 per share Price paid in the reported transaction
Holdings after transaction 126,004 shares Directly owned common shares after the purchase
Net buy shares 5,004 shares Net change in common stock position from this Form 4
open-market purchase financial
"transaction_action: "open-market purchase" for 5,004 common shares at $1.00"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
Common Stock financial
"security_title: "Common Stock" with 5,004 shares purchased"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"This Form 4 reports a single non-derivative open-market purchase"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dizon Romeo R

(Last)(First)(Middle)
1212 TERRA BELLA AVENUE

(Street)
MOUNTAIN VIEW CALIFORNIA 94043

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/26/2026P5,004A$1126,004D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Nilo De Castro, Attorney-in-fact for Romeo R. Dizon05/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did IRIDEX CORP (IRIX) report for Romeo R. Dizon?

IRIDEX CORP reported that Chief Financial Officer Romeo R. Dizon bought 5,004 shares of common stock. The purchase was an open-market transaction at $1.00 per share, reflecting a personal investment decision by a senior executive.

How many IRIDEX CORP (IRIX) shares does Romeo R. Dizon hold after this transaction?

After the reported transaction, Romeo R. Dizon directly holds 126,004 shares of IRIDEX CORP common stock. This figure includes the newly purchased 5,004 shares acquired in the open market at $1.00 per share.

Was the IRIDEX CORP (IRIX) insider transaction a buy or a sell?

The insider transaction was a buy. Romeo R. Dizon executed an open-market purchase of 5,004 IRIDEX CORP common shares at $1.00 per share, increasing his directly owned position reported on the Form 4.

What price did Romeo R. Dizon pay per share for IRIDEX CORP (IRIX) stock?

Romeo R. Dizon paid $1.00 per share for IRIDEX CORP common stock. He acquired 5,004 shares in an open-market purchase, bringing his total direct holdings to 126,004 shares following the transaction.

Does the IRIDEX CORP (IRIX) Form 4 show any derivative security exercises?

No derivative security exercises are shown in this Form 4. The filing reports only a single non-derivative transaction: an open-market purchase of 5,004 common shares at $1.00 per share by Romeo R. Dizon.